Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identifying the highest risk vascular patients: Insights from the XATOA registry.
Anand SS, Aboyans V, Bosch J, Debus S, Gay A, Patel MR, Vogtländer K, Welsh RC, Zeymer U, Fox KAA; XATOA Steering Committee. Anand SS, et al. Among authors: patel mr. Am Heart J. 2024 Mar;269:191-200. doi: 10.1016/j.ahj.2024.01.001. Epub 2024 Jan 12. Am Heart J. 2024. PMID: 38218425 Free article.
Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study.
Douglas PS, Pontone G, Hlatky MA, Patel MR, Norgaard BL, Byrne RA, Curzen N, Purcell I, Gutberlet M, Rioufol G, Hink U, Schuchlenz HW, Feuchtner G, Gilard M, Andreini D, Jensen JM, Hadamitzky M, Chiswell K, Cyr D, Wilk A, Wang F, Rogers C, De Bruyne B; PLATFORM Investigators. Douglas PS, et al. Among authors: patel mr. Eur Heart J. 2015 Dec 14;36(47):3359-67. doi: 10.1093/eurheartj/ehv444. Epub 2015 Sep 1. Eur Heart J. 2015. PMID: 26330417 Free PMC article.
PACE: randomized, controlled, multicentre, multinational, phase III study of PLX-PAD for critical limb ischaemia in patients unsuitable for revascularization: randomized clinical trial.
Norgren L, Weiss N, Nikol S, Lantis JC, Patel MR, Hinchliffe RJ, Reinecke H, Volk HD, Reinke P, Fadini GP, Ofir R, Rothenstein D, Halevy N, Karagjozov M, Rundback JH. Norgren L, et al. Among authors: patel mr. Br J Surg. 2024 Jan 31;111(2):znad437. doi: 10.1093/bjs/znad437. Br J Surg. 2024. PMID: 38294084 Free PMC article. Clinical Trial.
Frameworks for procurement, integration, monitoring, and evaluation of artificial intelligence tools in clinical settings: A systematic review.
Khan SD, Hoodbhoy Z, Raja MHR, Kim JY, Hogg HDJ, Manji AAA, Gulamali F, Hasan A, Shaikh A, Tajuddin S, Khan NS, Patel MR, Balu S, Samad Z, Sendak MP. Khan SD, et al. Among authors: patel mr. PLOS Digit Health. 2024 May 29;3(5):e0000514. doi: 10.1371/journal.pdig.0000514. eCollection 2024 May. PLOS Digit Health. 2024. PMID: 38809946 Free PMC article.
Framework of the Strengths and Challenges of Clinically Integrated Trials: An Expert Panel Report.
Peters AE, Jones WS, Anderson B, Bramante CT, Broedl U, Hornik CP, Kehoe L, Knowlton KU, Krofah E, Landray M, Locke T, Patel MR, Psotka M, Rockhold FW, Roessig L, Rothman RL, Schofield L, Stockbridge N, Trontell A, Curtis LH, Tenaerts P, Hernandez AF. Peters AE, et al. Among authors: patel mr. Am Heart J. 2024 May 23:S0002-8703(24)00124-8. doi: 10.1016/j.ahj.2024.05.009. Online ahead of print. Am Heart J. 2024. PMID: 38795793
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
Saba NF, Wong SJ, Nasti T, McCook-Veal AA, McDonald MW, Stokes WA, Anderson AM, Ekpenyong A, Rupji M, Abousaud M, Rudra S, Bates JE, Remick JS, Joshi NP, Woody NM, Awan M, Geiger JL, Shreenivas A, Samsa J, Ward MC, Schmitt NC, Patel MR, Higgins KA, Teng Y, Steuer CE, Shin DM, Liu Y, Ahmed R, Koyfman SA. Saba NF, et al. Among authors: patel mr. JAMA Oncol. 2024 May 23:e241143. doi: 10.1001/jamaoncol.2024.1143. Online ahead of print. JAMA Oncol. 2024. PMID: 38780927
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.
Harrington J, Hellkamp AS, Mahaffey KW, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Fox KAA, Singer DE, Goodman SG, Patel MR, Piccini JP. Harrington J, et al. Among authors: patel mr. J Am Heart Assoc. 2024 Jun 4;13(11):e028951. doi: 10.1161/JAHA.122.028951. Epub 2024 May 23. J Am Heart Assoc. 2024. PMID: 38780169 Free article. Clinical Trial.
Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumors.
Chen JJ, Vincent MY, Shepard D, Peereboom D, Mahalingam D, Battiste J, Patel MR, Juric D, Wen PY, Bullock A, Selfridge JE, Pant S, Liu J, Li W, Fyfe S, Wang S, Zota V, Mahoney J, Watnick RS, Cieslewicz M, Watnick J. Chen JJ, et al. Among authors: patel mr. Commun Med (Lond). 2024 May 21;4(1):95. doi: 10.1038/s43856-024-00520-z. Commun Med (Lond). 2024. PMID: 38773224 Free PMC article.
A Phase 1 dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results.
Hamilton E, Oliveira M, Turner N, García-Corbacho J, Hernando C, Ciruelos EM, Kabos P, Borrego MR, Armstrong A, Patel MR, Vaklavas C, Twelves C, Boni V, Incorvati J, Brier T, Gibbons L, Klinowska T, Lindemann JPO, Morrow CJ, Sykes A, Baird R. Hamilton E, et al. Among authors: patel mr. Ann Oncol. 2024 May 8:S0923-7534(24)00138-8. doi: 10.1016/j.annonc.2024.04.012. Online ahead of print. Ann Oncol. 2024. PMID: 38729567 Free article.
1,271 results